Voyager Therapeutics, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
VYGR Nasdaq 2836 www.voyagertherapeutics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Voyager Therapeutics, Inc.

Voyager Receives FDA IND Clearance for VY1706, First Gene Therapy Approach to Reducing Tau Production in the Brain for Alzheimer’s Disease - Jun 1st, 2026 6:00 am
What Voyager Therapeutics Inc (VYGR) Has Gained on Its Therapy Programs - May 20th, 2026 6:35 am
Voyager ASGCT Late Breaker: Single IV Dose of VY1706 Well Tolerated, Reduced Tau in 3-Month GLP Toxicology Data; Clinical Trial in Alzheimer’s Disease Expected H2 2026 - May 13th, 2026 4:01 am
Voyager Therapeutics (VYGR) Reports Q1 Loss, Misses Revenue Estimates - May 7th, 2026 3:55 pm
Voyager Reports First Quarter 2026 Financial and Operating Results - May 7th, 2026 2:01 pm
Voyager IV-Delivered CNS Gene Therapies Featured in Multiple Presentations at ASGCT 2026, Including Late Breaker on Tau-Targeted VY1706 for Alzheimer’s Disease - Apr 27th, 2026 2:31 pm
Voyager Therapeutics Conference: CEO Calls 2026 “Year of Tau,” Eyes BBB Capsid Clinic Debut - Mar 22nd, 2026 9:03 pm
Does Voyager Therapeutics’ (VYGR) Widening Annual Loss Redefine the Risk-Reward in Its Neurology Pipeline? - Mar 12th, 2026 4:06 pm
Voyager Therapeutics (VYGR) Reports Q4 Loss, Beats Revenue Estimates - Mar 9th, 2026 3:15 pm
Voyager Therapeutics: Q4 Earnings Snapshot - Mar 9th, 2026 2:22 pm
Voyager Reports Fourth Quarter and Full Year 2025 Financial and Operating Results - Mar 9th, 2026 2:01 pm
Voyager Therapeutics Touts Tau, Gene Therapy and NeuroShuttle Roadmap, Sees Cash Runway Into 2028 - Mar 2nd, 2026 3:03 am
Fortrea Holdings Inc. (FTRE) Q4 Earnings and Revenues Lag Estimates - Feb 26th, 2026 7:55 am
Voyager to Present at Upcoming Investor Conferences - Feb 9th, 2026 6:00 am
Gene Therapy Market Outlook 2026-2031, Featuring Profiles of REGENXBIO, Oxford Biomedica, Voyager Therapeutics and More - Jan 23rd, 2026 4:01 am
Voyager Therapeutics (VYGR): Strong Q3 Prompts Bullish Coverage - Dec 10th, 2025 12:14 pm
We're A Little Worried About Voyager Therapeutics' (NASDAQ:VYGR) Cash Burn Rate - Nov 24th, 2025 5:21 am
Voyager Therapeutics (VYGR) Reports Q3 Loss, Tops Revenue Estimates - Nov 10th, 2025 7:15 am
Voyager Therapeutics: Q3 Earnings Snapshot - Nov 10th, 2025 6:14 am
Transition Bio and Voyager Announce Collaboration to Advance Small Molecules Targeting TDP-43 in ALS and Frontotemporal Dementia - Nov 10th, 2025 6:01 am